TPG Capital, alongside the Canada Pension Plan Investment Board, will acquire IMS Health, one of the world’s leading providers of market intelligence to the pharmaceutical and healthcare industries, in a deal valued at $5.2bn.
In order to view premium content you need to be a Premium Subscriber. You can subscribe now to access premium online content.
Become a Premium SubscriberIf you are already a AltAssets subscriber please log in below.